EP
GMED icon

Eversept Partners’s Globus Medical GMED Stock Holding History

Eversept Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-169,643
Closed -$10M – 91
2025
Q2 		$10M Sell
169,643
-23,250
-12% -$1.5M 0.92% 33
2025
Q1 		$14.1M Buy
+192,893
New +$15.9M 1.43% 26

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Eversept Partners's GMED Position: Q3 2025 in Review

Eversept Partners sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 169,643 shares — an estimated $10M sold.

Eversept Partners first reported a position in GMED in Q1 2025 and held it in 2 quarters. The position peaked at $14.1M in Q1 2025. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Eversept Partners reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
  • Eversept Partners sold 169,643 Globus Medical shares in Q3 2025, an estimated $10M.
  • Eversept Partners first reported a position in Globus Medical in Q1 2025 and held it in 2 quarters.
  • Eversept Partners's Globus Medical position peaked at $14.1M in Q1 2025.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Eversept Partners's 13F filing for Q3 2025, filed 14 Nov 2025.